While U.S. cervical cancer rates have fallen by 70% since the 1950s thanks to the Pap test and national screening programs, the disease remains a leading killer of women in low- and middle-income countries for lack of access to screening and trained providers.
Kathleen Schmeler, M.D., professor of Gynecologic Oncology and Reproductive Medicine, is working change this. Her work to prevent and treat cervical cancer has taken...
An immunotherapy used against advanced non-small cell lung cancer is being tested at MD Anderson for a different...
Each year in the U.S., more than 50,000 people will be diagnosed with pancreatic cancer, which ranks around the 10th most common cancer type...
Prostate cancer is the most common cancer diagnosed in American men, and the second leading cause of cancer death in men. While hormone-based therapies are effective for many men, there remain an estimated 20% of patients who will not benefit and have significantly worse outcomes.
These patients have a subtype of prostate cancer known as aggressive variant prostate cancer (AVPC), which does not respond to therapies that block...
MD Anderson Cancer Center researchers, together with collaborators from Mozambique, Brazil and the U.S., have been awarded a $5.1 million...
Fewer than 30% of the women in the U.S. with abnormal, benign lesions known as atypical hyperplasia (AH) and lobular carcinoma in situ (LCIS...
In Texas, the number is even lower. Only 33% of Texas teens were up to date. That’s a lot of room for improvement.
Having spent the...
World Cancer Day is Saturday, Feb. 4. It’s the one singular initiative under which the entire world unites to fight cancer through prevention...
Certain quality-of-life factors, such as pain and anxiety, have a significant impact on the likelihood of endometrial cancer survivors to...
Three years ago, Stephen Cadmus faced a dilemma. He needed to see a doctor, but he had no health insurance.
To get the medical...